About us

The US 858, 954 patent is granted.

The US patent, method for treating disease or condition susceptible to ameliorationby AMPK activators and compounds of formula which are useful to activateAMP-activated protein kinase (AMPK) (13/858,954), is granted since we applied to USPTO in 2013.

Pattern covers the medical indications using the ENRGI platform, such as treatments of wound healing, metabolic disorders and others.